Procter & Gamble Health Ltd

  • BSE Code : 500126
  • NSE Symbol : PGHL
  • ISIN : INE199A01012
  • Industry :PHARMACEUTICALS - MULTINATIONAL

up-arrow 5,427.50 16.00(0.30%)

Open Price ()

5,405.00

Prev. Close ()

5,411.50

Volume (No’s)

6,019

Market Cap ()

8,982.76

Low Price ()

5,363.50

High Price ()

5,459.00

 

Corporate Announcement

04-Sep-2026 Procter & Gamble Health Limited - Updates
03-Sep-2026 Procter & Gamble Health Limited - Shareholders meeting
12-Aug-2026 Procter & Gamble Health Limited - Shareholders meeting
06-Aug-2026 Procter & Gamble Health Limited - Press Release
04-Jun-2026 Procter & Gamble Health Limited - Analysts/Institutional Investor Meet/Con. Call Updates

Stock Summary

Market Cap(₹Cr.)

8,980.51

P/E (TTM)

26.95

Book value ()

316.01

Div Yield (%)

3.79

EPS (TTM)

200.73

Face Value ()

10.00

Technical Analysis

Key Level

Resistance 1

5,487.17

Resistance 2

5,562.83

Support 1

5,319.17

Support 2

5,226.83

Moving Average

30 Days

5,855.32

50 Days

6,184.48

100 Days

5,981.82

200 Days

5,638.68

Peers Group

Company Market Cap (₹in Cr.) P/E (x) P/B(x) EV / EBITDA(x) Dividend Yield(%) EPS
Procter & Gamble Health L.. 8,980.51 26.95 15.18 474 3.79 200.73
Sun Pharmaceutical Indust.. 441,957.50 138.81 18.85 6053.68 0.87 13.27
Divis Laboratories Ltd 247,576.00 82.64 9.43 3921 0.32 112.85
Torrent Pharmaceuticals L.. 189,233.01 92.27 16.9 4001.11 0.68 53.92
Zydus Lifesciences Ltd 111,670.55 30.64 3.7 5426 0.09 36.54

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made investment of Returns(%)

in Months Ago

My investment would be worth with a Loss of

Share Holding

CATEGORY NO. OF SHARES PERCENTAGE (%)
Total Foreign 1467016 8.84
Total Institutions 2064492 12.44
Total Govt Holding 0 0.00
Total Non Promoter Corporate Holding 397297 2.39
Total Promoters 8601071 51.82
Total Public & others 4069506 24.53
Total 16599382 100
  • Total Foreign
  • Total Institutions
  • Total Govt Holding
  • Total Non Promoter Corporate Holding
  • Total Promoters
  • Total Public & others

Corporate Actions

About Company

Procter & Gamble Health Limited was erstwhile incorporated as E Merck (India) Limited in 1967. The Company's name was changed from E Merck (India) Limited to Merck Limited on March 27, 2002. Later, the name of the Company was changed to Procter & Gamble Health Limited on 6 May, 2019. The company was set up to take over the business of the Indian branch of Emeda Exports with all their assets and liabilities. The company is a 51% subsidiary of German firm Merck KGaA, is a leading player in vitamin formulations.

Procter & Gamble Health Limited is an Indian-based company principally engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals. The company is the supplier of Pharmaceutical Chemicals, Formulated Chemical Products, Chemicals, Industrial Chemicals, Chemicals, Pharmaceutical Industry, and Chemical Products.

The company offers prescription drugs, biotechnology products, and consumer health products, including over-the-counter products. They also offer products for the treatment of cancer, neurodegenerative diseases, infertility, endocrine and metabolic disorders, cardiovascular diseases, and other conditions with unmet medical needs.

The company operates in two business divisions, namely Pharmaceuticals and Chemicals. The Pharmaceutical...

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew